Clinical trial

A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

NCT00546286

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-05-31

PhasePHASE3

Study timeline

Study start (actual)2006-05-31Date precision: day

Registry last updated2017-04-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

dorzolamide hydrochloride (+) timolol maleateDRUG

Comparator: dorzolamide HCl/timolol maleate + prostaglandinDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00546286 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.